The efficacy and safety of memantine for the treatment of Alzheimer's disease
S Matsunaga, T Kishi, I Nomura, K Sakuma… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Currently, five pharmacotherapeutic options are available to treat Alzheimer's
disease: memantine; the three cholinesterase inhibitors donepezil, galantamine, and …
disease: memantine; the three cholinesterase inhibitors donepezil, galantamine, and …
Clinical profile of donepezil in the treatment of Alzheimer's disease
RS Doody - Gerontology, 1999 - karger.com
Although the underlying pathogenesis of Alzheimer's disease (AD) is not fully understood,
one of its key features is the widespread loss of central cholinergic innervation, known to be …
one of its key features is the widespread loss of central cholinergic innervation, known to be …
A risk-benefit assessment of dementia medications: systematic review of the evidence
JS Buckley, SR Salpeter - Drugs & aging, 2015 - Springer
Background There is no cure for dementia, and no treatments exist to halt or reverse the
course of the disease. Treatments are aimed at improving cognitive and functional …
course of the disease. Treatments are aimed at improving cognitive and functional …